U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872138) titled 'S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis' on March 06.
Brief Summary: This study aims to evaluate both serum and urine S100A8 as potential biomarkers for Lupus nephritis (LN)
Study Start Date: Nov. 01, 2024
Study Type: OBSERVATIONAL
Condition:
S100A8
Serum
Urine
Biomarker
Lupus Nephritis
Recruitment Status: RECRUITING
Sponsor: Theodor Bilharz Research Institute
Information provided by (Responsible Party): Ghada Khalifa Sayed, Theodor Bilharz Research Institute
Published by HT Digital Content Services with permission from Health Daily Digest....